Clear cell renal cell carcinoma (ccRCC) is usually incurable once it progresses to metastatic stage. Hence, in-depth investigations to reveal the precise molecular mechanisms behind the metastasis of ccRCC are required to improve the therapeutic outcome of ccRCC.
Background
Clear cell renal cell carcinoma (ccRCC) is one of the most common and aggressive renal carcinomas worldwide [1, 2] . Recently, great advances in functional genomics analysis has provided increased understanding of renal carcinoma tumorigenesis and development [2] . Nevertheless, the molecular pathogenesis of advanced ccRCC remains poorly investigated. Hence, development for more effective therapeutic strategy is urgently needed to combat ccRCC [3] . The aggressiveness of ccRCC is based on its high metastatic capacity, which is usually not efficiently targeted despite great advances in the treatment of metastatic ccRCC [4] . Metastasis is critical for the progression of ccRCC; it is one of the hallmarks of tumor progression and is the primary cause of poor over-all survival of ccRCC patients [5] .
Astrocyte elevated gene1 (AEG-1) is cloned by rapid subtraction hybridization as a gene induced in primary human fetal astrocytes (PHFA) infected with HIV-1 or treated with tumor necrosis factor-a (TNF-a) [6] . Previous studies reveal that AEG-1 is overexpressed in breast carcinoma [7] , melanoma [8] , and glioma [9] compared to their normal counterparts. Overexpression of AEG-1 increases the anchorage-independent growth, migration, and invasion of HeLa cells and glioma cell lines [9] . Conversely, downregulation of AEG-1 remarkably suppresses the mobility and invasion of prostate cancer cells, glioma cells [10] , and lung metastatic of breast cancer cells in vivo [7] . Inhibition of AEG-1 in prostate cancer cells inhibits protein kinase B (PKB) activation and increases the activity of forkhead box (FOXO) 3a [11] . Together, these results suggest that AEG-1 is a crucial gene regulating multiple signaling and biochemical pathways in cancer progression. Nevertheless, the level of AEG-1 in ccRCC and the underlying mechanism by which AEG-1 facilitates the metastasis of ccRCC cells have not yet been explored.
In this study we demonstrated that AEG-1 plays vital roles in growth and metastasis of ccRCC Caki-2 cells in vitro and in vivo. The functions of AEG-1 in the metastatic ability of ccRCC Caki-2 cells was revealed by knock-down and overexpression of AEG-1. Finally, we found that AEG-1 promoted ccRCC cells migration and invasion by regulating Notch1 expression. In conclusion, our results reveal the critical roles of AEG-1/Notch1 in the growth and metastasis of ccRCC.
Material and Methods

Cells cultures and tissue microarray
Three ccRCC cell lines (Caki-2, 786-O, and Caki-1) and an immortalized proximal tubule epithelial cell line (HK-2) were from the Cell Bank of the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Caki-2, 786-O, and Caki-1 cells were cultured using DMEM supplemented with FBS (10%), 100 μg/ml streptomycin, and 100 μg/ml penicillin. HK-2 cells were cultured in 1640 supplemented with FBS (10%), 100 μg/ml streptomycin, and 100 μg/ml penicillin. The inhibitor of Notch, FLI-06, was purchased from Selleck (Houston, TX, USA). Fifty cases of human ccRCC tissues and paired surrounding tissues were histopathologically and clinically diagnosed at the First People's Hospital of Jining City from 2002 to 20016. Prior patient consent and approval from the Institutional Research Ethics Committee were obtained. Tissues were probed using human AEG-1 antibody.
Oncomine analysis
Oncomine (https://www.oncomine.org/resource/login.html) is a powerful platform that contains cancer microarray data for bioinformatics analysis. The expression level of AEG-1 gene in ccRCC was analyzed using Oncomine [12] . For this, we compared clinical specimens of ccRCC versus normal tissues. To reduce our false discovery rate, we selected p<0.01 and fold change >1 as thresholds. We analyzed the results for their p-values and fold change. Oncomine analysis of neoplastic vs. normal tissue showed that AEG-1 was significantly overexpressed in the Jones Renal ccRCC dataset [13] and Gumz Renal ccRCC dataset [14] .
Cells proliferation and colony formation assay
Cell proliferation was detected by MTS assay (Promega, Madison, WI, USA). First, Caki-2 cells were cultured into 96-well plates. After incubation for 1 day, 2 days, 3 days, or 4 days, 20 μl of MTS solution was added into 96-well plates and the cells were incubated for 4 h. Finally, the absorbance value was assessed at 490 nm. In colony formation analysis, cells (1000) were seeded into 6-well plates. After being cultured for a total of 3 weeks, cell colonies were stained using crystal violet (0.1%) and counted [15] .
Plasmids and transfections
Short hairpin small interfering RNA (shRNA) specifically targeting AEG-1 was purchased from Santa Cruz (Santa Cruz, CA, USA). AEG-1 expression construct was produced by subcloning PCR-amplified full-length human AEG-1 cDNA into pMSCV retrovirus plasmid. The pCLEN-Notch1 plasmid (#17704, Addgene, Cambridge, MA, USA) was deposited by Dr. Nicholas Gaiano. Transfection of shRNA or plasmid was conducted using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).
Immunoblotting
Total proteins were extracted using lysis buffer. We resolved 25 µg proteins by 8% SDS-PAGE and transferred them to a 8214 PVDF membrane (Millipore, USA). After blocking with blocking buffer, PVDF membranes were incubated with primary antibodies. After washing with TBST, PVDF membranes were incubated with horseradish peroxidase (HRP) secondary antibody. Signals were assessed using the ECL system (Millipore, Braunschweig, Germany).
Wound-healing and invasion assay
Cells were cultured in 6-well plates to form a confluent monolayer. A wound was scratched using a 100-µl pipette tip. The gap was photographed at 0 h and 24 h [16] . The invasion of Caki-2 cells was detected using a BioCoat™ Matrigel-coated Invasion Chamber (8.0-µm membrane, BD Biosciences, USA). We placed 1×10 5 Caki-2 cells into the upper chamber and 600 µl DMEM containing 25% serum was added to the lower chamber as a chemo-attractant. After 6 h, the invaded Caki-2 cells in the lower surface of the membrane were stained with crystal violet (0.1%) and were counted in 5 randomly selected fields [17] .
Immunofluorescence
Cells on a glass coverslip were permeabilized using Triton X-100 and then incubated with 1% BSA in PBS to block non-specific binding. Then, Caki-2 cells were incubated with rabbit anti-AEG-1 antibody. The cells were washed with PBS 3 times and then were incubated with goat anti-rabbit FITC secondary antibody (1: 100, Boster Biological Technology, Wuhan, China). Cell nuclei were stained using DAPI (Boster Biological Technology).
Experimental pulmonary metastasis model
The BALB/c nude mice were bought from Shanghai Slack Laboratory Animal Co., LTD (Shanghai, China). The parental Caki-2 cells, AEG-1 OE, or Caki-2 transfected with AEG-1 shRNA plasmids were injected into nude mice via the tail vein. All nude mice were sacrificed after 4 weeks and lung tissue was fixed using 10% formalin and subjected to hematoxylin and eosin (H&E) staining.
Quantitative real-time PCR (qRT-PCR)
RNA was extracted using the RNEasy kit (Qiagen). We performed qRT-PCR using 1 μg RNA with the QuantiTect Reverse Transcription kit (Qiagen). The primers were as follows: GAPDH: Forward: 5'-TGGATTTGGACGCATTGGTC-3', Reverse: 5'-TTTGCACTGGTACGTGTTGAT-3'; AEG-1: Forward: 5'-AAATGGG CGGACTGTTGAAGT-3', Reverse: 5'-CTGTTTTGCACTGCTTTAGCAT-3'; Notch1: Forward: 5'-CCCTTGCTCTGCCTAACGC-3', Reverse: 5'-GGAGTCCTGGCATCGTTGG-3'. The comparative cycle threshold (Ct) method was used to quantify the levels calculated using the 2 (-DDCt) method.
Xenografts
The nude mice were assigned to the following 2 groups: AEG-1 shRNA and shCon (control group). Then, 100 μl of Caki-2 (AEG-1shRNA/control-shRNA) cell suspension containing 1×10 6 cells was subcutaneously inoculated into nude mice. The tumor sizes were measured once a week. Five weeks later, the mice were sacrificed and the tumors were removed for further IHC staining. Experimental protocols involving animals were approved by the Institutional Animal Care and Use Committee of the First People's Hospital of Jining City in Shandong Province.
Statistical analysis
The data are presented as mean ± standard deviation (SD). Differences were analyzed using either a 2-tailed t test or 1-way ANOVA followed by post hoc Dunnett's test. P < 0.05 was considered to be statistically significant.
Results
AEG-1 is overexpressed in ccRCC and positively correlates with its progression
To determine the level of AEG-1 in ccRCC, the expression of AEG-1 was analyzed in ccRCC tissues and adjacent non-cancer tissues. Representative hematoxylin and eosin (H&E) staining of ccRCC tissues and representative results of immunohistochemistry (IHC) for AEG-1 in ccRCC tissues is shown ( Figure 1A ). As shown in Figure 1B , the level of AEG-1 was distinctly higher in ccRCC tissues than that in the surrounding normal tissues. Further analysis showed that AEG-1 was remarkably higher in ccRCC tissues at the late American Joint Committee on Cancer (AJCC) stages than that in the AJCC early stage ( Figure 1C ). To further test AEG-1 overexpression in kidney cancer, we utilized a panel of 4 ccRCC cell lines (Caki-2, 786-O, Caki-1, and OS-RC-2) and HK-2 cells (an immortalized proximal tubule epithelial cell line) to examine relative AEG-1 mRNA expression by qRT-PCR. A shown in Figure 1D , AEG-1 was overexpressed in ccRCC cell lines. Consistently, the mRNA level of AEG-1 was significantly increased in ccRCC compared to corresponding normal kidney tissues in the Jones Renal ccRCC dataset [13] and Gumz Renal ccRCC dataset [14] ( Figure 1E, 1F) . These results suggest that AEG-1 was aberrantly overexpressed in ccRCC and positively correlated with kidney cancer progression.
Endogenous AEG-1 regulates ccRCC cells metastasis
To future confirm that AEG-1 is responsible for the metastasis of the ccRCC cells, AEG-1 shRNA was transfected into Caki-2 or 786-O cells to establish AEG-1-under-expressing cells ( Figure 2A AEG-1 dramatically increased the metastasis of ccRCC cells as evidenced by accelerated migration and invasion ( Figure  3B, 3C) . Finally, to explore whether AEG-1 regulated ccRCC cell metastasis in vivo, the control cells (AEG-1-OE) or shAEG-1 ccRCC cells were injected into the tail vein. As shown in Figure 3D , the metastatic foci formed by AEG-1-OE Caki-2 or AEG-1-OE 786-O cells were remarkably increased; conversely, AEG-1 knockeddown cells resulted in less lung metastasis lesions. These results proved the crucial role of AEG-1 in ccRCC cells metastasis.
AEG-1 induces ccRCC cells metastasis via regulating Notch1
To further reveal the mechanisms by which AEG-1-regulated ccRCC cells metastasize, we performed qRT-PCR analysis in the scramble cells and AEG-1 under-expression Caki-2 cells. Twenty-eight cancer metastasis-associated genes were analyzed and we found the most downregulated gene in AEG-1-depleted Caki-2 cells was Notch1 ( Figure 4A ). Importantly, we confirmed that AEG-1 knock-down inhibited the protein level of Notch1 in Caki-2 cells ( Figure 4B ). To further explore the function of Notch1 in AEG-1-induced metastasis of ccRCC cells, pCLEN-Notch1 (a constitutively active form of Notch1) was transfected into AEG-1-silenced Caki-2 cells ( Figure 4C ). The migration and invasion of Caki-2 cells was analyzed using the wound-healing and Transwell assays, respectively. As expected, pCLEN-Notch1 transfection rescued the impaired migration and invasion ability in the AEG-1-silenced Caki-2 cells ( Figure 4D, 4E) . Furthermore, the Notch1 inhibitor (FLI-06) was also applied to assess the function of Notch1 in the migration and invasion of ccRCC cells [18] . As shown in Figure 4F , the expression of Notch1 in AEG-1-overexpressing Caki-2 cells was decreased by FLI-06. Consistently, the migration and invasion activity of Caki-2 cells promoted by AEG-1 overexpression was also suppressed by FLI-06 ( Figure 4G, 4H) . Altogether, these results suggest that AEG-1/Notch1 signaling plays a vital role in the metastasis of ccRCC cells.
Oncogenic activity of AEG-1 in the xenografted model
To finally explore the impact of AEG-1 on ccRCC cells growth in vivo, an athymic nude mouse xenografted model was examined. Photographs of the tumors at necropsy and the measured volumes of the tumors indicated that AEG-1-depleated Caki-2 cells grew much more slowly than control cells ( Figure 5A ). The weights of the tumors from these mice were remarkably lower than those from the control mice ( Figure 5B ). We performed IHC to further assess the expression of AEG-1 and Notch1 in tumor tissues. As shown in Figure 5C , 5D, the expression of AEG-1 and Notch1 in the AEG-1 shRNA group was significantly decreased compared with that in the control group. Collectively, these results suggested that AEG-1 acted as a tumor promoter in ccRCC and that depletion of AEG-1 dramatically attenuated ccRCC oncogenic properties in vivo.
Discussion
Clear cell renal cell carcinoma (ccRCC) is a malignant cancer with high mortality owing to its high metastatic potential [14, 19] . Hence, there is urgent need to explore the underlying mechanisms of metastasis in ccRCC [20] . In the present study, we revealed that AEG-1 promoted the metastasis of ccRCC cells via regulating Notch1. These results suggest that AEG-1 can serve as a potential target for inhibiting ccRCC metastasis. AEG-1 is overexpressed in various cancers and is involved into tumor metastasis [21] . In papillary thyroid cancer, AEG-1 is closely related to the progression and metastasis of disease [22] . Knock-down of AEG-1 reduces the abilities of migration and invasion through downregulation of MMP-2/9 in thyroid cancer cells. The mRNA level of AEG-1 is markedly higher in lung cancer cells than that that in the normal bronchial epithelial cell line and the higher mRNA level of AEG-1 is correlated with clinical stages and lymph node metastasis of NSCLC [23] . In addition, overexpression of AEG-1 is associated with metastasis in patients with gastric cancer, and AEG-1 promotes gastric cancer cells metastasis via upregulation of eIF4E-mediated Twist and MMP-9 [24] . Altogether, these findings prove the vital roles of AEG-1 in tumorigenesis. Nevertheless, the functions of AEG-1 in ccRCC metastasis have not yet been explored. In this research, we revealed the precise role of AEG-1 in ccRCC metastasis. We found that the migration and invasion of Caki-2 cells was remarkably suppressed when the AEG-1 gene was knocked-down by shRNA, as demonstrated by wound-healing analysis and Transwell assay. In contrast, In vertebrates there are 4 Notch genes (Notch1, Notch2, Notch3, and Notch4), which encode receptors for at least 5 different DSL Notch ligands, including Jagged1, Jagged2, Delta1, Delta3, and Delta4 [25] . In cancer progression, Notch acts as either an oncogene or tumor suppressor gene depending on the cancer type [26] . A previous study demonstrated that overexpression of Notch signaling increases the metastasis of T1 stage ccRCC through stimulating the growth and migration of tumor cells [27] . In our study, the molecular mechanism of AEG-1-regulated ccRCC cells metastasis was proved to be associated with Ntoch1. This study demonstrates that AEG-1 knockeddown decreased the expression of Notch1 in ccRCC Caki-2 cells. Furthermore, restoration of Notch1 in AEG-1 knocked-down Caki-2 via transfection with an active form of Notch1 rescued the decreased migration and invasion of Caki-2 cells caused by AEG-1 silencing. Additional, in the presence of the Notch inhibitor, FLI-06, the migration and invasion of Caki-2 cells promoted by AEG-1 overexpression were markedly inhibited, which suggests the vital role of Notch1 in AEG-1-induced ccRCC cell metastasis.
Conclusions
To identify novel targets for inhibiting ccRCC metastasis, it is necessary to identify effective biomarkers and key genes that mediate the metastasis of ccRCC. Our study revealed the crucial roles of AEG-1 in the metastasis of ccRCC cells, which suggests AEG-1 as a potential target for treating ccRCC metastasis.
